Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7 (2)

Effects of Eight Weeks of High Intensity Functional Training on Glucose Control and Body Composition Among Overweight and Obese Adults


Effects of Eight Weeks of High Intensity Functional Training on Glucose Control and Body Composition Among Overweight and Obese Adults

Yuri Feito et al. Sports (Basel).


High-intensity exercise has been found to positively influence glucose control, however, the effects of high-intensity functional training (HIFT) for overweight and obese sedentary adults without diabetes is unknown. The purpose of this study was to examine changes in body composition and glucose control from eight weeks of aerobic and resistance training (A-RT) compared to HIFT. Session time spent doing daily workouts was recorded for each group. Baseline and posttest measures included height, weight, waist circumference, dual X-ray absorptiometry (body fat percentage, fat mass, lean mass), and fasting blood glucose. Participants completing the intervention (78%, n = 9 per group) were 67% female, age = 26.8 ± 5.5 years, and had body mass index = 30.5 ± 2.9 kg/m². Fasting blood glucose and 2-h oral glucose tolerance tests were used as primary outcome variables. On average, the HIFT group spent significantly less time completing workouts per day and week (ps < 0.001). No significant differences were found for body composition or glucose variables within- or between-groups. Even though our findings did not provide significant differences between groups, future research may utilize the effect sizes from our study to conduct fully-powered trials comparing HIFT with other more traditional training modalities.

Keywords: CrossFit; diabetes; exercise; fitness.

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles


    1. Rosella L.C., Lebenbaum M., Fitzpatrick T., O’Reilly D., Wang J., Booth G.L., Stukel T.A., Wodchis W.P. Impact of diabetes on healthcare costs in a population-based cohort: A cost analysis. Diabet. Med. 2016;33:395–403. doi: 10.1111/dme.12858. - DOI - PMC - PubMed
    1. American Diabetes Association Economic costs of diabetes in the U.S. In 2017. Diabetes Care. 2018;41:917–928. doi: 10.2337/dci18-0007. - DOI - PMC - PubMed
    1. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M., Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403. - PMC - PubMed
    1. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. doi: 10.1001/jama.289.1.76. - DOI - PubMed
    1. Fallahzadeh H., Ostovarfar M., Lotfi M.H. Population attributable risk of risk factors for type 2 diabetes; bayesian methods. Diabet. Metab. Syndrome Cli. Res. Rev. 2019 doi: 10.1016/j.dsx.2019.01.015. in press. - DOI